--(BUSINESS WIRE)-- D&D Pharmatech, Inc. (D&D), a clinical-stage biotechnology ... hepatic steatosis by >50% in only 4 weeks with up to 100% of subjects achieving ≥30% liver fat reduction by MRI-PDFF.
Some results have been hidden because they may be inaccessible to you